Lp(a) lipoprotein as a risk factor for myocardial infarction.

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Journal of the American Medical Association (JAMA)

• Publication date

  1986-11-14

• Fields of study

  Medicine

• Identifiers
  DOI 10.1001/JAMA.1986.03380180102027PMID 2945939
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A NEW SERUM TYPE SYSTEM IN MAN--THE LP SYSTEM.

  2009cited by this paper
• Characterization of the Lp(a) lipoprotein in human plasma.

  2009cited by this paper
• A re-examination of major locus hypotheses for high density lipoprotein cholesterol level using 2,170 persons screened in 55 Utah pedigrees.

  1986cited by this paper
• Levels of lipoprotein Lp(a) decline with neomycin and niacin treatment.

  1985cited by this paper
• Relationship of Plasma Lipoprotein Lp(a) Levels to Race and to Apolipoprotein B

  1985cited by this paper
• Genetics of the Lp lipoprotein in Japanese‐Americans

  1985cited by this paper
• Primary and familial hypoalphalipoproteinemia.

  1984cited by this paper
• The inheritance of high density lipoprotein cholesterol and apolipoproteins A-I and A-II.

  1984cited by this paper
• Apolipoproteins and lipoproteins of human plasma: significance in health and in disease.

  1983cited by this paper
• Apolipoproteins and lipoproteins of human plasma: significance in health and in disease.

  1983cited by this paper
• NIH conference. Type III hyperlipoproteinemia: diagnosis, molecular defects, pathology, and treatment.

  1983cited by this paper
• The genetics of quantitative plasma Lp(a): analysis of a large pedigree.

  1983cited by this paper
• The LDL receptor locus in familial hypercholesterolemia: multiple mutations disrupt transport and processing of a membrane receptor.

  1983cited by this paper
• Type III Hyperlipoproteinemia: Diagnosis, Molecular Defects, Pathology, and Treatment

  1983cited by this paper
• Epidemiologic Analysis with a Programmable Calculator

  1982cited by this paper
• Lp(a) lipoprotein enters cultured fibroblasts independently of the plasma membrane low density lipoprotein receptor

  1981cited by this paper
• Complex segregation analysis of the Lp(a)/pre-beta 1-lipoprotein trait.

  1981cited by this paper
• Complex segregation analysis of the Lp(a)/pre‐ß1‐lipoprotein trait

  1981cited by this paper
• Determinants of blood pressure in Japanese-American families

  1980cited by this paper
• Insulin response to an oral glucose load in relation to Lp(a)/pre-beta 1-lipoprotein levels in non-diabetic patients with peripheral vascular disease and in controls.

  1979cited by this paper
• Coronary risk factors and autopsy findings in Japanese-American men.

  1978cited by this paper
• Serum lipids in angiographically assessed coronary atherosclerosis.

  1978cited by this paper
• Sinking pre-beta lipoprotein and coronary heart disease in Japanese-American men in Hawaii.

  1978cited by this paper
• Major loci for lipoprotein concentrations.

  1978cited by this paper
• Radioimmunoassay of human plasma Lp(a) lipoprotein.

  1977cited by this paper
• Simple estimation of population attributable risk from case-control studies.

  1977cited by this paper
• Serum lipoproteins and coronary heart disease in a population study of Hawaii Japanese men.

  1976cited by this paper
• Familial hyper-alpha-lipoproteinemia: studies in eighteen kindreds.

  1975cited by this paper
• Usefulness of community surveillance for the ascertainment of coronary heart disease and stroke.

  1975cited by this paper
• Some factors related to coronary heart disease incidence in Honolulu Japanese men: the Honolulu Heart Study.

  1975cited by this paper
• Lp(a) lipoprotein/pre‐ß1‐lipoprotein in Swedish middle‐aged males and in patients with coronary heart disease

  1975cited by this paper
• A study of methods of identification and estimation of Lp(a) lipoprotein and of its significance in health, hyperlipidaemia and atherosclerosis.

  1974cited by this paper
• Quantitative genetic studies of the human plasma Lp(a) lipoprotein

  1974cited by this paper
• Lp(a) lipoprotein and pre‐β1‐lipoprotein in patients with coronary heart disease

  1974cited by this paper
• The genetics of the Lp Antigen

  1974cited by this paper
• Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia.

  1973cited by this paper
• A New Serum Type System in Man — The Ld System

  1965cited by this paper
• Heredity in hypertension.

  1963cited by this paper
• HEREDITY IN HYPERTENSION

  1934cited by this paper

• Atherogenic dyslipidaemia and residual cardiovascular risk: Understanding the link to heart disease

  2026influential citation
• Lipoprotein(a) and Cerebral Venous Sinus Thrombosis: A Case and the Evidence

  2025cites this paper
• Lp(a): A clinical review.

  2025cites this paper
• Lipoprotein (a) and myocardial infarction: impact on long-term mortality

  2023cites this paper
• Lipoprotein(a) As a Risk Factor in a Cohort of Hospitalised Cardiovascular Patients: A Retrospective Clinical Routine Data Analysis

  2023cites this paper
• Lipoprotein(a): Just an Innocent Bystander in Arterial Hypertension?

  2023cites this paper
• A SHORT STUDY ON THE CLINICO PATHOLOGICAL CORRELATION OF SERUM HOMOCYSTEINE LEVEL

  2020cites this paper
• Rendimiento diagnóstico de la secuenciación de genes de hipercolesterolemia familiar en sujetos con hipercolesterolemia primaria

  2020cites this paper
• Diet and Lp(a): Does Dietary Change Modify Residual Cardiovascular Risk Conferred by Lp(a)?

  2020cites this paper
• Diagnostic yield of sequencing familial hypercholesterolemia genes in individuals with primary hypercholesterolemia.

  2020cites this paper
• Lipoprotein(a) and its Clinical Importance

  2020cites this paper
• Relation of High Lipoprotein (a) Concentrations to Platelet Reactivity in Individuals with and Without Coronary Artery Disease

  2020cites this paper
• Role of Lipoprotein (a) in Coronary Artery Disease

  2019cites this paper
• Lipoprotein(a): An underrecognized genetic risk factor for malignant coronary artery disease in young Indians

  2019cites this paper
• Comparative Study of Lipoprotein (A) Level in Patients of Acute Coronary Syndrome with Type II Diabetes and Non Diabetics in a Tertiary Care Hospital of Central India

  2018cites this paper
• Relationship between Lipoprotein ( a ) and Acute Myocardial Infarction

  2018cites this paper
• Lipoprotein(a) and Atherosclerosis: A Case Report and Literature Review

  2018cites this paper
• COMPARISON OF SERUM LIPOPROTEIN (A) LEVEL IN TYPE 2 DM AND NON-DIABETIC PATIENTS WITH ACUTE CORONARY SYNDROME

  2018cites this paper
• Lipoprotein(a): new insights from modern genomics

  2017cites this paper
• Some Effects of Exposure Misclassification on Epidemiological Studies

  2017cites this paper
• Comparative Study of Lipoprotein (A) Level in Type 2 Diabetics and Non Diabetics with Acute Coronary Syndrome

  2016cites this paper
• Estimating the Population Impact of Lp(a) Lowering on the Incidence of Myocardial Infarction and Aortic Stenosis—Brief Report

  2016cites this paper
• Lipoprotein (a) as a cause of cardiovascular disease: insights from epidemiology, genetics, and biology

  2016cites this paper
• Structure, function, and genetics of lipoprotein (a)

  2016cites this paper
• ENDOTHELIAL FUNCTION Does Lipoprotein(a) Impair Endothelial Function?

  2016cites this paper
• Combined Supplementation with Grape Pomace and Omija Fruit Ethanol Extracts Dose-Dependently Improves Body Composition, Plasma Lipid Profiles, Inflammatory Status, and Antioxidant Capacity in Overweight and Obese Subjects

  2016cites this paper
• DYSLIPIDEMIA IN UREMIC PATIENTS TREATED WITH INTERMITTENT DIALYSIS

  2016cites this paper
• Anti-atherogenic Potential of Natural Honey： Anti-diabetic and Antioxidant Approaches

  2015cites this paper
• The analysis of

  2015cites this paper
• Interaction between dietary factors and genetic risk for lipoprotein traits and cardiovascular disease

  2015cites this paper
• An elevated lipoprotein(a) plasma level as a cardiovascular risk factor.

  2015cites this paper
• Weitere kardiovaskuläre Ereignisse trotz Apherese

  2015cites this paper
• Lipoprotein (a): Structure, Pathophysiology and Clinical Implications

  2014cites this paper
• The Impact of hemodialysis and continuous peritoneal dialysis on lipoprotein(a) concentration and Apolipoprotein(a) Phenotypes in Patients with End Stage Renal Disease

  2014cites this paper
• Effect of Pitavastatin on Vascular Reactivity in Hypercholesterolemic Rabbits

  2014cites this paper
• Venous and Arterial Thrombosis

  2014cites this paper
• Low-molecular-weight lipoprotein (a) and low relative lymphocyte concentration are significant and independent risk factors for coronary heart disease in patients with type 2 diabetes mellitus: Lp(a) phenotype, lymphocyte, and coronary heart disease

  2013cites this paper
• Genetics of Lipoprotein(a) in Relation to Coronary Heart Disease

  2013cites this paper
• LIPOPROTEIN(A) IN CEREBRAL STROKE: A REVIEW

  2012cites this paper
• Lipoprotein (a) – An Overview

  2012cites this paper
• Anti-inflammatory and metabolic actions of FXR: insights into molecular mechanisms.

  2012cites this paper
• Association study of lipoprotein(a) genetic markers, traditional risk factors, and coronary heart disease in HIV-1-infected patients

  2012cites this paper
• Genetics of coronary artery disease: genome-wide association studies and beyond.

  2012cites this paper
• Maternal cardiac risks in pre-eclamptic patients

  2012cites this paper
• Role of apheresis in the management of familial hypercholesterolemia and elevated Lp(a) levels

  2011cites this paper
• Lipoprotein a levels in pediatric migraine.

  2011cites this paper
• Role of homocysteine and lipoprotein (A) in atherosclerosis: An update

  2011cites this paper
• Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in African Americans and Caucasians: The Atherosclerosis Risk in Communities (ARIC) Study

  2011cites this paper
• Farnesoid X receptor represses hepatic human APOA gene expression.

  2011cites this paper
• patients with chronic stable angina pectoris Elevated plasma lipoprotein(a) is associated with coronary artery disease in

  2011cites this paper
• Transactivation versus transrepression in FXR: lessons learned from other Nuclear Receptors

  2011cites this paper
• Oxidized phospholipids on apoB-100-containing lipoproteins: a biomarker predicting cardiovascular disease and cardiovascular events.

  2011cites this paper
• Associations Between Lipoprotein(a) Levels and Cardiovascular Outcomes in Black and White Subjects: The Atherosclerosis Risk in Communities (ARIC) Study

  2011cites this paper
• Lipoprotein ( a ) Lp ( a ) ELISA Enzyme Immunoassay for the Determination of Lipoprotein a [ Lp ( a ) ] in Human Serum , Citrate and EDTA Plasma

  2010cites this paper
• リポ蛋白（a）の著明高値をみとめた脳静脈洞血栓症の1例

  2010cites this paper
• Guias de practicas de laboratorio clinico Biomarcadores emergentes para la prevencion primaria de la enfermedad cardiovascular y del accidente cerebrovascular Capitulos 7 al 10

  2010cites this paper
• Inflammation and dyslipidaemia: a possible interplay between established risk factors in North Indian males with coronary artery disease

  2010cites this paper
• inhibitor 2 in human blood monocytes Lipoprotein (a) up-regulates the expression of the plasminogen activator

  2010cites this paper
• Enigmatic Role of Lipoprotein(a) in Cardiovascular Disease

  2010cites this paper
• Emerging Biomarkers for Primary Prevention of Cardiovascular Disease and Stroke

  2009cites this paper
• Effect of over-the-counter fish-oil administration on plasma Lp(a) levels in an end-stage renal disease population.

  2009cites this paper
• Lipoprotein (a) [Lp(a)]: a possible link between migraine and stroke.

  2009cites this paper
• Cardiovascular events in patients with increased lipoprotein (a) - retrospective data analysis in an outpatient department of lipid disorders.

  2009cites this paper
• Lipoprotein (a) in patients with psoriasis: associations with lipid profiles and disease severity

  2009cites this paper
• Review Article Genetics of coronary artery disease: focus on genome- wide association studies

  2009cites this paper
• A Physiological Function for Apolipoprotein(a): A Natural Regulator of the Inflammatory Response

  2009cites this paper
• All-Cause Mortality and Competing Risks of Fatal and Nonfatal Vascular Events in the Italian Longitudinal Study on Aging: Impact of Lipoprotein(a)

  2009cites this paper
• Genetics of coronary artery disease: focus on genome-wide association studies.

  2009cites this paper
• Antiphospholipid antibodies and lipoprotein(a) in obese children

  2009cites this paper
• Aterosklerotik Koroner Arter Hastalığında Bir Risk Göstergesi Olarak Lipoprotein (a)'nın Değeri THE VALUE OF LIPOPROTEIN(a) AS A PREDICTOR OF ATHEROSCLEROTIC CORONARY ARTERY DISEASE

  2008cites this paper
• Dyslipidemia: End Stage Renal Disease and Hemodialysis

  2008cites this paper
• Association of serum lipoprotein (a) with hypertension in diabetic patients.

  2008cites this paper
• The apolipoprotein(a) gene: linkage disequilibria at three loci differs in African Americans and Caucasians.

  2008cites this paper
• Serum Lp(a) in diabetics with and without evidence of clinical nephropathy—A preliminary study

  2008cites this paper
• Markers of Chlamydia pneumoniae and human cytomegalovirus infection in patients with chronic peripheral vascular disease and their relation to inflammation, endothelial dysfunction and changes in lipid metabolism

  2008cites this paper
• Serial intravascular ultrasound assessment of coronary atherosclerosis progression and remodeling

  2008cites this paper
• Prevalence and biologic profile of aspirin resistance in patients with angiographically proven coronary artery disease.

  2007cites this paper
• Comparison of Lipoprotein(a) Levels between Elderly and Middle‐Aged Men with Coronary Artery Disease

  2007cites this paper
• Oxidized Phospholipids, Lipoprotein(a), Lipoprotein-Associated Phospholipase A2 Activity, and 10-Year Cardiovascular Outcomes: Prospective Results From the Bruneck Study

  2007cites this paper
• Lipoprotein (a) and venous thromboembolism in adults: a meta-analysis.

  2007cites this paper
• Lipoprotein (a) and apolipoprotein (a) phenotypes in healthy Macedonian children.

  2007cites this paper
• Lipoproteins, Vascular-Related Genetic Factors, and Human Longevity

  2007cites this paper
• Fish intake and LPA 93C>T polymorphism: Gene-environment interaction in modulating lipoprotein (a) concentrations

  2007cites this paper
• From Carotid Plaque Biology to Serologic Markers of Vulnerability to Predict the Risk of Cerebrovascular Events

  2007cites this paper
• Fish intake and LPA 93C>T polymorphism: gene-environment interaction in modulating lipoprotein (a) concentrations.

  2007cites this paper
• An Orthomolecular Theory of Human Health and Disease

  2007cites this paper
• ipoprotein (a) and Venous Thromboembolism in Adults: Meta-Analysis

  2007cites this paper
• Serum level of lipoprotein (a) is inversely associated with the development of coronary collateral circulation

  2006cites this paper
• A Physician Guide to LDL Apheresis Therapy

  2006cites this paper
• Relation between lipoprotein(a) and fibrinogen and serial intravascular ultrasound plaque progression in left main coronary arteries.

  2006cites this paper
• Lipoprotein(a): a unique risk factor for cardiovascular disease.

  2006cites this paper
• Concentraciones elevadas de lipoproteína(a) en plasma en pacientes psiquiátricos: una posible contribución al aumento del riesgo vascular

  2006cites this paper
• Elevated plasma levels of lipoprotein(a) in psychiatric patients: a possible contribution to increased vascular risk

  2006cites this paper
• Efficacy and tolerability of combined treatment with L-carnitine and simvastatin in lowering lipoprotein(a) serum levels in patients with type 2 diabetes mellitus.

  2006cites this paper
• Aortic valve calcification in systemic lupus erythematosus

  2006cites this paper
• Reduction of Serum L Prostatic Cancer poprotein ( a ) by Estrogen in Men with

  2006cites this paper
• Lipoprotein(a), measured with an assay independent of apolipoprotein(a) isoform size, and risk of future cardiovascular events among initially healthy women.

  2006cites this paper
• Lipoprotein (a) and comprehensive lipid tetrad index as a marker for coronary artery disease in NIDDM patients in South India.

  2006cites this paper
• Apo[a] size and PNR explain African American-Caucasian differences in allele-specific apo[a] levels for small but not large apo[a] Published, JLR Papers in Press, February 22, 2006.

  2006cites this paper
• Elevated lipoprotein(a)--a genetic risk factor for premature vascular disease in people with and without standard risk factors: a review.

  2006cites this paper